Part 1. Introduction

• 1.1 Market Definition
• 1.2 Key Benefit
• 1.3 Market Segment

Part 2. Methodology

• 2.1 Primary
• 2.2 Secondary

Part 3. Executive Summary

Part 4. Market Overview

• 4.1 Introduction
• 4.2 Market Size and Forecast
• 4.3 Market Dynamics
  • 4.3.1 Drivers
  • 4.3.2 Restraints
• 4.4 Impact of COVID-19 Pandemic

Part 5. Digital Therapeutics Market in Europe, by Application

• 5.1 Cardiovascular Diseases
  • 5.1.1 Market Size and Forecast
• 5.2 Central Nervous System (Cns) Diseases
  • 5.2.1 Market Size and Forecast
• 5.3 Diabetes
  • 5.3.1 Market Size and Forecast
• 5.4 Gastrointestinal Disorder
  • 5.4.1 Market Size and Forecast
• 5.5 Obesity
  • 5.5.1 Market Size and Forecast
• 5.6 Respiratory Diseases
  • 5.6.1 Market Size and Forecast
• 5.7 Smoking Cessation
  • 5.7.1 Market Size and Forecast
• 5.8 Others
  • 5.8.1 Market Size and Forecast

Part 6. Digital Therapeutics Market in Europe, by Product

• 6.1 Devices
  • 6.1.1 Market Size and Forecast
• 6.2 Software
  • 6.2.1 Market Size and Forecast

Part 7. Digital Therapeutics Market in Europe, by Distribution

• 7.1 Business-To-Business (B2B)
  • 7.1.1 Market Size and Forecast
• 7.2 Business-To-Consumers (B2C)
  • 7.2.1 Market Size and Forecast

Part 8. Digital Therapeutics Market in Europe, by Region

• 8.1 France
  • 8.1.1 Market Size and Forecast
• 8.2 Germany
  • 8.2.1 Market Size and Forecast
• 8.3 Italy
  • 8.3.1 Market Size and Forecast
• 8.4 Russia
  • 8.4.1 Market Size and Forecast
• 8.5 Spain
  • 8.5.1 Market Size and Forecast
• 8.6 Uk
  • 8.6.1 Market Size and Forecast
• 8.7 Rest Of Europe
  • 8.7.1 Market Size and Forecast

Part 9. Key Competitor Profiles

• 9.1 ADA Health GmbH
• 9.2 Caterna Vision GmbH
• 9.3 Cognifit
• 9.4 Fitbit, Inc.
• 9.5 Kaia Health Software Inc.
• 9.6 Medtronic PLC.
• 9.7 Novartis International AG
• 9.8 Resmed, Inc.
• 9.9 Sonormed GmbH
• 9.10 Voluntis, Inc.

*LIST IS NOT EXHAUSTIVE

Part 10. Patent Analysis

• 10.1 Patent Statistics
• 10.2 Regional Analysis
• 10.3 Trends Analysis

DISCLAIMER

ABOUT GEN CONSULTING COMPANY

The digital therapeutics market in Europe is projected to grow at a compound annual growth rate (CAGR) of 19.43% during the forecast period 2021-2027, according to the new report published by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into digital therapeutics market in Europe. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, company share of market leaders, growth rate and market segments.

The digital therapeutics market is segmented on the basis of application, product, distribution, and region. The digital therapeutics market is segmented as below:

By Application:
- cardiovascular diseases
- central nervous system (CNS) diseases
- diabetes
- gastrointestinal disorder
- obesity
- respiratory diseases
- smoking cessation
- others

By Product:
- devices
- software

By Distribution:
- Business-to-Business (B2B)
- Business-to-Consumers (B2C)

By Region:
- region
- France
- Germany
- Italy
- Russia
- Spain
- UK
- Rest of Europe

The digital therapeutics industry is characterized by a high level of market share concentration. The market research report covers the analysis of key stake holders of the digital therapeutics market. Some of the leading players profiled in the report include ADA Health GmbH, Caterna Vision GmbH, Cognifit, Fitbit, Inc., Kaia Health Software Inc., Medtronic PLC., Novartis International AG, Resmed, Inc., Sonormed GmbH, Voluntis, Inc., among others.
*list is not exhaustive, request free sample to get a complete list of companies

Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report
- To analyze and forecast the market size of the digital therapeutics market in Europe.
- To classify and forecast the digital therapeutics market in Europe based on application, product, distribution, and region.
- To identify drivers and challenges for the digital therapeutics market in Europe.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the digital therapeutics market in Europe.
- To conduct pricing analysis for the digital therapeutics market in Europe.
- To identify and analyze the profile of leading players operating in the digital therapeutics market in Europe.

Why Choose This Report
- Gain a reliable outlook of the digital therapeutics market in Europe forecasts from 2021 to 2027 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.